Plain-English translation of NCT06804135 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is investigating how radiation therapy — one of the main treatments for cervical cancer — affects your immune system. Researchers will collect small blood samples and tumor tissue at different points during your radiation treatment to see how your body's natural defenses respond to the therapy.
Most cervical cancer studies have not carefully examined how different types and doses of radiation therapy impact the immune system. This trial aims to fill that gap by collecting detailed immune information from patients receiving various radiation schedules, which could help doctors better understand and improve treatment outcomes.
You likely qualify if…
You likely don't qualify if…
You will receive your regular radiation therapy as planned by your cancer care team. In addition, you will have extra blood draws and small tissue biopsies taken at specific time points before, during, and after your radiation course. These samples will be analyzed in the laboratory to measure how your immune system is responding. The study involves 110 participants total, divided into different groups based on their radiation treatment plan.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
India
Sponsor
Tata Memorial Hospital
Enrollment target
~110 participants
Started
October 2025
Primary completion
January 2029
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dr. Supriya Chopra
Tata Memorial Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.